• Tips gratefully accepted here. Thanks!:

  • Recent Comments

    Ivory Bill Woodpecke… on Redlining is evil
    Ga6thDem on Redlining is evil
    Ga6thDem on Harris
    Ivory Bill Woodpecke… on Redlining is evil
    eurobrat on Harris
    lililam on VEEP Stakes.
    William on VEEP Stakes.
    riverdaughter on Redlining is evil
    Ga6thDem on Redlining is evil
    Ga6thDem on VEEP Stakes.
    Ga6thDem on VEEP Stakes.
    William on Harris
    riverdaughter on VEEP Stakes.
    riverdaughter on Harris
    Kathleen A Wynne on VEEP Stakes.
  • Categories


  • Tags

    abortion Add new tag Afghanistan Al Franken Anglachel Atrios bankers Barack Obama Bernie Sanders big pharma Bill Clinton cocktails Conflucians Say Dailykos Democratic Party Democrats Digby DNC Donald Trump Donna Brazile Economy Elizabeth Warren feminism Florida Fox News General Glenn Beck Glenn Greenwald Goldman Sachs health care Health Care Reform Hillary Clinton Howard Dean John Edwards John McCain Jon Corzine Karl Rove Matt Taibbi Media medicare Michelle Obama Michigan misogyny Mitt Romney Morning Edition Morning News Links Nancy Pelosi New Jersey news NO WE WON'T Obama Obamacare OccupyWallStreet occupy wall street Open thread Paul Krugman Politics Presidential Election 2008 PUMA racism Republicans research Sarah Palin sexism Single Payer snark Social Security Supreme Court Terry Gross Texas Tim Geithner unemployment Wall Street WikiLeaks women
  • Archives

  • History

    July 2013
    S M T W T F S
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  
  • RSS Paul Krugman: Conscience of a Liberal

  • The Confluence

    The Confluence

  • RSS Suburban Guerrilla

    • Here we go again
      This is one more reason why Biden will need to expand the federal bench and add a couple hundred new judges: @fedjudges reports the White House is nominating Kathryn Kimball Mizelle, an associate at Jones Day, and former clerk to Justice Thomas, to a lifetime-tenured judgeship in Florida. She graduated college in 2009, earned her … Continue reading Here we g […]
  • RSS Ian Welsh

    • Biden Picks Kamala Harris As VP
      The two most important consequences of this decision come from the fact that Biden is old and almost certainly senile. This means that Harris stands a good chance of becoming President if Biden dies or his incapacity becomes un-concealeable even with the best drug cocktails. If that doesn’t happen, Kamala is odds on to be […]
  • Top Posts

What’s wrong with these people, er, this picture?

Screen Shot 2013-07-19 at 7.18.27 AM

Oo! Oo!  I know how to fix this!  Maybe we can take the fines from the banks like Chase, who now consider fines just protection money they have to pay so they can keep doing what they want, and use it to make Detroit solvent.  Or would we hear whining from Wall Street that it is unfaaaaair to redistribute our country’s tax dollars to the unworthy?

Assholes

****************************************

In another story of bad deed doing, Glaxo Smith Kline (GSK) is creating an international incident in China where it has been accused of bribing government officials and doctors with about $500 million in order to raise the price of their prescription drugs.  Note that it was probably the testosterone and amphetamine soaked sales department that came up with this brilliant idea.  Now, China is forbidding GSK’s finance director from leaving the country.  What a splendid idea!  Maybe we should send all of our misbehaving finance directors to China.  Derek Lowe has more on the story.

If I recall correctly, the GSK research site in Shanghai was also accused of some falsification of data that lead to publications being pulled from Nature.  Hey, the management in China wanted to show it could get publications in Nature so it did- by lying.  For a brief time there, the Shanghai site was probably held up as a model of research brilliance by the executive class to all of the other global, loser “centers of excellence” at GSK.  That ought to give the King of Prussia, PA site a nice warm and fuzzy feeling.  We shouldn’t be surprised by the China syndrome.  One of my Chinese colleagues told me that China wasn’t like the US in terms of business infrastructure and relatively low levels of corruption but that only time would prove to the executive class that China wasn’t ready for a world class research industry.

It’s also GSK that proposed to pay their scientists million dollar bonuses if a drug candidate goes blockbuster.  Read Derek Lowe’s post on the topic for a run down of why this is a phenomenally bad idea.

GSK, this week’s poster child.